诺和诺德称Cagrisema的监管申请预计将在2025年底前提交。

金吾资讯
20 Dec 2024

金吾财讯 | 诺和诺德(NVO)发言人:完整的Cagrisema结果将在明年的医学大会上公布。我们计划优化剂量调整,进一步探索Cagrisem作为额外减肥潜力,计划在2025年上半年开始一项新的试验。Cagrisema的监管申报预计将于2025年底进行。我们对Cagrisema的特性感到鼓舞,它看起来安全、耐受性良好,并且与其他GLP-1s广泛相似。

Source Link

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Most Discussed

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10